Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | FABP3 | P05413 | 5/20 | 0.47 |
| ▸ | FABP7 | O15540 | 4/20 | 0.47 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1538258 | 0.82 | ALDH1A1 (0.60) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL4082182 | 0.82 | ALDH1A1 (0.56) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL31748924 | 0.82 | ALDH1A1 (0.60) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL878536 | 0.79 | ALDH1A1 (0.61) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL28010762 | 0.79 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL12128703 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL7737365 | 0.79 | ALDH1A1 (0.57) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL7181428 | 0.79 | ALDH1A1 (0.65) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL29901836 | 0.79 | ALDH1A1 (0.65) | ALDH1A1HSD17B10GAAPGRPTGS1 | |
| SCHEMBL37865 | 0.79 | ALDH1A1 (0.65) | ALDH1A1HSD17B10GAAPGRPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107179366-B | The high-throughput non-targeted screening identification method of organo-chlorine pollutant in a kind of deposit | 南京大学 | 2019-11-05 | — | — | CN | disclosed |
| CN-107179366-A | The non-targeted examination authentication method of organo-chlorine pollutant high flux in a kind of deposit | 南京大学 | 2017-09-19 | — | — | CN | disclosed |
| US-20160349088-A1 | MONITORING DEVICES AND PROCESSES BASED ON TRANSFORMATION, DESTRUCTION AND CONVERSION OF NANOSTRUCTURES | PATEL GORDHANBHAI (US) | 2016-12-01 | — | — | US | disclosed |
| EP-2475612-A1 | MONITORING DEVICES AND PROCESSES BASED ON TRANSFORMATION, DESTRUCTION AND CONVERSION OF NANOSTRUCTURES | JP LABORATORIES, INC. (US) | 2012-07-18 | — | — | EP | disclosed |
| US-20110071319-A1 | METHOD FOR PREPARING HALOGENATED ORGANOPHOSPHINES | CYTEC CANADA INC. (CA) | 2011-03-24 | — | — | US | disclosed |
| EP-2297171-A2 | METHOD FOR PREPARING HALOGENATED ORGANOPHOSPHINES | Cytec Canada Inc. (CA) | 2011-03-23 | — | — | EP | disclosed |
| WO-2011031959-A1 | MONITORING DEVICES AND PROCESSES BASED ON TRANSFORMATION, DESTRUCTION AND CONVERSION OF NANOSTRUCTURES | JP LABORATORIES, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| US-20110003279-A1 | Monitoring devices and processes based on transformation, destruction and conversion of nanostructures | PATEL GORDHANBHAI NATHALAL | 2011-01-06 | — | — | US | disclosed |
| WO-2009147495-A2 | METHOD FOR PREPARING HALOGENATED ORGANOPHOSPHINES | CYTEC CANADA INC. (CA) | 2009-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071319-A1 | METHOD FOR PREPARING HALOGENATED ORGANOPHOSPHINES | NR1H3, NR1H2, LPAR3 | ALDH1A1 3748/4885HSD17B10 470/4885GAA 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.